Piromidic Acid

Piromidic Acid

SCHEMBL134848

CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 1.00
CASP1 P29466 1/20 1.00
KDM4E B2RXH2 6/20 0.66
MAPK1 P28482 3/20 0.66
CYP2C9 P11712 1/20 0.66
ENPP2 Q13822 10/20 0.65
MEN1 O00255 1/20 0.65
ALDH1A1 P00352 1/20 0.65
HPGD P15428 1/20 0.65
KMT2A Q03164 1/20 0.65
HSD17B10 Q99714 1/20 0.65
PDE4A P27815 1/20 0.64
PDE4B Q07343 1/20 0.64
PDE4C Q08493 1/20 0.64
PDE4D Q08499 1/20 0.64
NPSR1 Q6W5P4 1/20 0.62
TDP1 Q9NUW8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piromidic Acid SCHEMBL29479929 1.00 LMNA (1.00) LMNACASP1KDM4EMAPK1CYP2C9
SCHEMBL26193584 0.99 LMNA (0.98) LMNACASP1KDM4EMAPK1CYP2C9
Piromidic Acid SCHEMBL7759092 0.99 LMNA (0.98) LMNACASP1KDM4EMAPK1CYP2C9
Pipemidic Acid SCHEMBL7160140 0.94 LMNA (0.88) LMNACASP1KDM4EMAPK1CYP2C9
Piromidic Acid SCHEMBL7854324 0.92 LMNA (0.84) LMNACASP1KDM4EMAPK1CYP2C9
SCHEMBL10123829 0.91 LMNA (0.83) LMNACASP1KDM4EMAPK1CYP2C9
SCHEMBL11582405 0.91 LMNA (0.83) LMNACASP1KDM4EMAPK1CYP2C9
SCHEMBL8236893 0.91 LMNA (0.83) LMNACASP1KDM4EMAPK1CYP2C9
Pipemidic Acid SCHEMBL29351712 0.90 LMNA (0.82) LMNACASP1KDM4EMAPK1CYP2C9
Pipemidic Acid SCHEMBL135557 0.90 LMNA (0.82) LMNACASP1KDM4EMAPK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3687 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4571306-A1 STABILIZING OXYGEN IN A COMPOSITION Instrumentation Laboratory Company (US) 2025-06-18 EP claimed
CN-120142412-A Stabilizing oxygen in a composition 仪器实验室公司 2025-06-13 CN claimed
US-20250189479-A1 STABILIZING OXYGEN IN A COMPOSITION INSTRUMENTATION LABORATORY COMPANY 2025-06-12 US claimed
EP-4554627-A1 INHALABLE FORMULATION FOR USE IN THE TREATMENT OF BACTERIAL LUNG INFECTIONS Solmic Biotech GmbH (DE) 2025-05-21 EP claimed
EP-4554939-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF Astrazeneca AB (SE) 2025-05-21 EP claimed
US-20250144088-A1 INHALABLE FORMULATION FOR USE IN THE TREATMENT OF BACTERIAL LUNG INFECTIONS Solmic Biotech GmbH (DE) 2025-05-08 US claimed
WO-2025080590-A1 CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS SCIENTIFIC HORIZONS CONSULTING LLC (US) 2025-04-17 WO claimed
US-12274830-B2 Nitric oxide inhalation therapy for infants with bronchiolitis BEYOND AIR LTD (IL) 2025-04-15 US claimed
US-20250115942-A1 SCREENING METHOD FOR ANTI-PSEUDOMONAL AGENTS AND COMPOSITIONS AND METHODS FOR TREATING PSEUDOMONAS INFECTIONS BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES 2025-04-10 US claimed
US-20250099557-A1 ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) 2025-03-27 US claimed
EP-0405858-B1 Control of aberrant expression vector accumulation during fermentation procedures LILLY CO ELI (US) 1995-07-19 EP claimed
US-5223246-A Powdered mixture of antibacterial oxo-carboxylic acids having fused nitrogen rings, carbonates, water soluble binders, for treatment of drinking water for livestock TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-06-29 US claimed
EP-0431080-A4 COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND CHROMATOGRAPHY 1992-10-21 EP claimed
EP-0443381-A1 Effervescent composition, its production and use Takeda Chemical Industries, Ltd. (JP) 1991-08-28 EP claimed
EP-0431080-A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND CHROMATOGRAPHY AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) 1991-06-12 EP claimed
EP-0405858-A2 Control of aberrant expression vector accumulation during fermentation procedures ELI LILLY AND COMPANY (US) 1991-01-02 EP claimed
WO-1990002141-A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND CHROMATOGRAPHY AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) 1990-03-08 WO claimed
US-4853225-A Process for implanting a medicament depot MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-08-01 US claimed
US-4563485-A SURGICAL IMPLANTS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1986-01-07 US claimed
US-3981999-A BACTERICIDES, PYRIMIDINE COMPOUNDS DAINIPPON PHARMACEUTICAL CO., LTD. (JA) 1976-09-21 US claimed